Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
12.25
+0.84 (7.36%)
At close: Jun 27, 2025, 4:00 PM
11.64
-0.61 (-4.98%)
After-hours: Jun 27, 2025, 6:17 PM EDT
Forte Biosciences Employees
Forte Biosciences had 14 employees as of December 31, 2024. The number of employees increased by 5 or 55.56% compared to the previous year.
Employees
14
Change (1Y)
5
Growth (1Y)
55.56%
Revenue / Employee
n/a
Profits / Employee
-$3,122,429
Market Cap
80.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
FBRX News
- 3 days ago - Forte Biosciences Announces Pricing of $75 Million Public Offering - Business Wire
- 4 days ago - Forte Biosciences Announces Proposed Public Offering - Business Wire
- 5 days ago - Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study - Business Wire
- 6 weeks ago - Forte Biosciences, Inc. Announces Results and Provides Update - Business Wire
- 3 months ago - Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Business Wire
- 5 months ago - Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - Business Wire
- 7 months ago - Forte Biosciences to Host R&D Day December 3, 2024 - Business Wire
- 7 months ago - Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications - Business Wire